Adipose derived stromal vascular fraction and fat graft for treating the hands of patients with systemic sclerosis. A randomized clinical trial
Open Access
- 14 August 2023
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 18 (8) , e0289594
Abstract
Background: Systemic Sclerosis in the hand is characteristically evidenced by Raynaud’s phenomenon, fibrosis of the skin, tendons, ligaments, and joints as well as digital ulcers with prolonged healing. Current medical treatment does not always cure these complications. Local adipose-derived stromal vascular fraction administration into the hands has been proposed as an emerging treatment due to its regenerative properties. The objective of this randomized controlled clinical trial was to evaluate the safety and clinical effects of fat micrografts plus adipose derived-stromal vascular fraction administration into the hands of patients with systemic sclerosis. Methods: This was an open-label, monocentric, randomized controlled study. Twenty patients diagnosed with systemic sclerosis were assigned to the experimental or control group. Fat micrografts plus the adipose derived-stromal vascular fraction were injected into the right hand of experimental group patients. The control group continued to receive only medical treatment. Demographic, serologic data and disease severity were recorded. Digital oximetry, pain, Raynaud phenomenon, digital ulcers number, mobility, thumb opposition, vascular density of the nail bed, skin affection of the hand, serologic antibodies, hand function, and quality of life scores were evaluated in both groups. Results: The results of the intervention were analyzed with the Wilcoxon rank test, and the differences between the control and experimental groups at 0 days and 168 days were analyzed with the Mann–Whitney U test. Adverse events were not observed in both groups. At the end of the study, statistically significant improvements were observed in pain levels (p<0.05) and number of digital ulcers (p<0.01) in the experimental vs control group. Conclusion: The injection of adipose derived-stromal vascular fraction plus fat micrografts is a reproducible, and safe technique. Pain and digital ulcers in the hands of patients with systemic sclerosis can be treated with this technique plus conventional medical treatment.Keywords
Funding Information
- Consejo Nacional de Ciencia y Tecnología, Mexico (10000/739/2017)
This publication has 37 references indexed in Scilit:
- Adipose tissue-derived stem cells in clinical applicationsExpert Opinion on Biological Therapy, 2013
- Evidence for progressive reduction and loss of telocytes in the dermal cellular network of systemic sclerosisJournal of Cellular and Molecular Medicine, 2013
- Adipose-Derived Stem Cells in Tissue Regeneration: A ReviewISRN Stem Cells, 2013
- Articular involvement in systemic sclerosisRheumatology, 2012
- Management of Raynaud's phenomenon and digital ulcers in systemic sclerosisJoint Bone Spine, 2011
- Two faces of the same coin: Raynaud phenomenon and digital ulcers in systemic sclerosisAutoimmunity Reviews, 2011
- Digital ulcers in scleroderma: staging, characteristics and sub-setting through observation of 1614 digital lesionsRheumatology, 2010
- Effect of tissue-harvesting site on yield of stem cells derived from adipose tissue: implications for cell-based therapiesCell and tissue research, 2008
- Human Adipose Tissue Is a Source of Multipotent Stem CellsMolecular Biology of the Cell, 2002
- Preliminary criteria for the classification of systemic sclerosis (scleroderma)Arthritis & Rheumatism, 1980